Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Roma Verona Study: Complete Revascularization Associated with Significant Improvement in LVEF and Long-Term Survival

Francesco Burzotta, MD, and Carlo Trani, MD, discuss the long-term outcome of the extent of revascularization in complex, high-risk patients indicated for Protected PCI.

Instituting a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute. 

What is the purpose of the STEMI DTU™ RCT?

This FAQ provides key information about the purpose and design of the STEMI DTU pivotal randomized controlled trial and how to participate.

FAQ: What Is the Clinical Evidence That Supports the Benefit of Placing the Impella® Heart Pump Pre-PCI?

A preponderance of evidence from the FDA cVAD Study, Impella Quality Database and the physician-initiated NSCI study supports the recommendation that placing Impella 2.5® or Impella CP® pre-PCI improves outcomes.

Data from the NCSI Study Demonstrates 72% Survival with 98% Native Heart Recovery

William O'Neill, MD, discusses data from the National Cardiogenic Shock Initiative (NCSI) study presented at the 2019 SCAI Scientific Sessions.

High-Risk PCI with Impella® Support and Atherectomy

Thom Dahle, MD, presents a high-risk PCI case managed with a heart team approach that entails Impella support and atherectomy.

Protected PCI with Impella® and Intravascular Lithotripsy with Shockwave

Robert Riley, MD, presents a high-risk PCI case requiring hemodynamic support with the Impella CP® heart pump and intravascular lithotripsy with Shockwave for vascular access.

Considerations for Impella vs. ECMO

Three physicians from the Cleveland Clinic discuss strategies for selecting the Impella® heart pump and/or ECMO as well as patient management and venting strategies.

Discussion of a Retrospective Matched-Pair Analysis Comparing Patients in Cardiogenic Shock Treated with Balloon Pump and the Impella® Heart Pump

Seth Bilazarian, MD, discusses the limitations of Schrage, Ibrahim, et al. published in Circulation comparing patients in cardiogenic shock treated with balloon pump and the Impella® heart pump. 

What is NCSI Study?

The NCSI Study is based on adopting the best practices algorithm focused on identifying shock early and unloading using Impella devices before PCI, reducing use of inotropes, and the use of invasive hemodynamic monitoring to aid in escalation and weaning.

What is the STEMI DTU™ Pilot Trial?

The STEMI DTU pilot trial demonstrated for the first time that LV unloading using the Impella CP® heart pump with a 30-minute delay before reperfusion is safe and feasible

What is A-CURE?

The clinical, preclinical, and basic research of A-CURE focuses primarily on the use of the Impella® heart pump, a transvalvular microaxial flow pump, as the means to unload the heart.

National Cardiogenic Shock Initiative: 1 Year Later

William O'Neill, MD, Cindy Grines, MD, FACC, FSCAI, and Navin K. Kapur, MD, FACC, FSCAI, FAHA, discuss NCSI data after 1 year.

How is Closure Managed with Impella® Heart Pumps?

Review the key steps of the manual compression technique.

What Size Access Sheath is Used with Impella® Heart Pumps?

Review the access sheath sized used for Impella heart pumps in this FAQ.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].